Stock Market News4 weeks Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO Yahoo Finance
Weight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO.
XWeight-loss drug developer Metsera targets up to $1.78 billion valuation in US IPO.
X